Stada buyout prescription finally shows results

Bain Capital and Cinven's €5.3bn buyout of German pharmaceuticals maker Stada went through this week, the firm announced on Friday, after a tense build up to Wednesday's midnight deadline, with the 63% shareholder acceptance threshold only just being reached.

  • By Max Bower
  • 18 Aug 2017

Only just over 63% of shares were tendered for the deal, having been counted throughout Thursday and the final result only announced on Friday morning.

Another source close to the situation had confirmed that only around 35% of shares had been tendered by the end of last week, ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 19,543.40 76 7.21%
2 BNP Paribas 17,658.36 110 6.52%
3 Goldman Sachs 15,275.80 61 5.64%
4 Deutsche Bank 14,293.34 81 5.27%
5 HSBC 14,165.38 91 5.23%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 6,956.59 58 7.34%
2 Goldman Sachs 6,746.86 54 7.12%
3 Deutsche Bank 5,912.17 58 6.24%
4 Credit Suisse 5,767.09 60 6.09%
5 BNP Paribas 5,158.30 56 5.45%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 33,611.94 263 10.79%
2 Citi 26,772.36 213 8.59%
3 Bank of America Merrill Lynch 25,057.11 221 8.04%
4 Goldman Sachs 23,500.21 166 7.54%
5 Barclays 20,380.66 139 6.54%